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Abstract
Background: Lung function at the end of life depends on its peak and subsequent decline. Because
obesity is epidemic in young adulthood, we quantified age-related changes in lung function relative
to body mass index (BMI).
Methods: The Coronary Artery Risk Development in Young Adults (CARDIA) study in 1985–86
(year 0) recruited 5,115 black and white men and women, aged 18–30. Spirometry testing was
conducted at years 0, 2, 5 and 10. We estimated 10 year change in FVC, FEV1 and FEV1/FVC
according to baseline BMI and change in BMI within birth cohorts with initial average ages 20, 24,
and 28 years, controlling for race, sex, smoking, asthma, physical activity, and alcohol consumption.
Measurements and Main Results: Participants with baseline BMI < 21.3 kg/m2 experienced 10
year increases of 71 ml in FVC and 60 ml in FEV1 and neither measure declined through age 38. In
contrast, participants with baseline BMI ≥ 26.4 kg/m2 experienced 10 year decreases of 185 ml in
FVC and 64 ml in FEV1. FEV1/FVC increased with increasing BMI. Weight gain was also associated
with lung function. Those who gained the most weight over 10 years had the largest decrease in
FVC, but FVC increased with weight gain in those initially thinnest. In contrast, FEV1 decreased with
increasing weight gain in all participants, with maximum decline in obese individuals who gained the
most weight during the study.
Conclusion: Among healthy young adults, increasing BMI in the initially thin participants was
associated with increasing then stable lung function through age 38, but there were substantial lung
function losses with higher and increasing fatness. These results suggest that the obesity epidemic
threatens the lung health of the general population.
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Background
Many studies find that lung function, as described by the
forced expiratory volume in one second (FEV1) and/or
forced vital capacity (FVC), is inversely correlated with
general, pulmonary, and cardiovascular mortality and
morbidity [1-3]. FEV1 and FVC at the end of life is a func-
tion of lung growth during childhood, peak function in
early adulthood, and subsequent decline related to aging
and insults such as cigarette smoking, air pollution, and
occupational exposures [4-8]. Peak lung function in early
adulthood is related to gender, race/ethnicity, cigarette
smoking, exposure to environmental tobacco smoke and
particulate air pollution [7-9]. In addition, lung function
is decreased by excess body fatness after adjusting for
other factors such as age, height, race, sex, asthma and
smoking status in populations that are at risk for reduced
lung function [10-19]. However, in the one study that has
evaluated the association between BMI and lung function
in the general population, the median age was 41 years
[20]. No study has evaluated the association between BMI
and future lung function in young adulthood.
In addition to increases in body weight with age [21],
there are widespread population secular trends of increas-
ing obesity [22]. In the US, the prevalence of obesity,
defined as a body mass index (BMI) >30 kg/m2, increased
from 12% in 1992 to 17.9% in 1998 and to 19.8% in
2000, across all age groups, races, genders and educa-
tional levels [23,24]. A recent paper has shown that the
prevalence of obesity has increased from 10.9% in 1996
to 22.1% in 2001 in young adults aged 19–26 years [25].
This obesity epidemic may cause a population-wide wors-
ening of lung function.
In the presence of secular and age-related increases in
weight and obesity, the goals of the present study were to
quantify age-related changes on FVC, FEV1, and the FEV1/
FVC ratio according to baseline BMI and BMI changes in
a large, generally healthy, cohort of black men, white
men, black women, and white women followed for 10
years. Our hypotheses were (1) greater BMI during young
adulthood is inversely related to lung function measures
later in life and (2) the effect of change in BMI on future
lung function is dependent on the participant's BMI at
baseline such that an increase in BMI increases lung func-
tion among those who were thin at baseline, but decreases
lung function among those with high baseline BMI.
Methods
Participants and Measurements
The data used in these analyses were collected in the Cor-
onary Artery Risk Development In Young Adults (CAR-
DIA) study, a multi-center cohort study occurring in the
US. The cohorts were recruited from the general popula-
tion, mostly by telephone, randomly sampled from a pre-
paid health plan in Oakland, CA and from populations in
Birmingham, AL, Chicago, IL, and Minneapolis, MN. The
response rate was approximately 50%, which was consid-
ered acceptable given the required long term commitment
to the study. The detailed methods, instruments and qual-
ity control procedures are described in other published
reports [26,27]. In 1985–86 (year 0), 5,115 black and
white men and women were recruited for the year 0 exam-
ination; 4,624 were reexamined in 1987–88 (year 2);
4,352 in 1990–91 (year 5); 4,086 in 1992–93 (year 7);
and 3,950 in 1995–96 (year 10). At year 0, CARDIA
included approximately equal numbers of participants
who were black and white, men and women, aged 18–24
and 25–30, and had more than or less than or equal to
high school education [26,27]. We excluded 58 partici-
pants who were outside the 18 through 30 age range at
year 0, 7 women who were pregnant at baseline, and any-
one missing baseline lung function, BMI, physical activity,
alcohol intake, or smoking, leaving 4,734 participants for
analysis. Of these, 4,277 attended year 2, 4,043 attended
year 5, and 3,668 attended year 10. We excluded 147
observations in women who were pregnant at followup
measurement of lung function, since pregnancy might
influence both BMI and lung function, but included
observations in those same women when not pregnant.
Clinic attendance was somewhat higher at the year 10
exam among whites (82%) than among blacks (73%).
The participants lost to follow-up after years 0, 2, or 5 did
not differ significantly in most of their year 0 characteris-
tics when compared with those observed at year 10. Spe-
cifically, both mean FVC and FEV1 at year 0 did not differ
significantly across those whose last examination
attended was year 0 (n = 203), 2 (n = 232), 5 (n = 221), 7
(n = 410), or 10 (n = 3668).
Measures
Body weight was measured in light clothing to the nearest
0.1 kg with a calibrated balance beam scale, height with-
out shoes was measured to the nearest 0.5 cm using a ver-
tical ruler, and BMI (kg/m2) computed.
Demographic characteristics, lifestyle habits, and medical
history were collected by self-report using a questionnaire.
Physical activity was measured using an interviewer-
administered questionnaire [28] concerning the fre-
quency of participation in 13 different activities during
the past 12 months. Because participants were not asked
specifically about duration of physical activity, exact
energy expenditure cannot be estimated and the activity is
expressed approximately in "Exercise Units" (EU). A score
of 100 EU is roughly equivalent to participation in activi-
ties such as a vigorous exercise class or bicycling faster
than 10 miles per hour, two or three hours a week for six
months of the year. Average weekly alcohol intake wasRespiratory Research 2008, 9:31 http://respiratory-research.com/content/9/1/31
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determined separately for beer, wine, and liquor. Smok-
ing status was categorized into four groups: never smok-
ers, ex-smokers, current smokers of ≤ 15 cigs/day, and
current smokers of >15 cigs/day. Asthma diagnosis [29]
was made at a given examination if the subject was taking
asthma medication (usually based on examination of
medicine containers) or self-report of a medical diagnosis
of asthma (not asked at year 5). The asthma variable had
three categories: asthma diagnosed before the beginning
of the study, asthma diagnosed during the study and peo-
ple that never had asthma diagnosed either before or dur-
ing the study.
Lung function was measured using a Collins Survey 8-liter
water sealed spirometer and an Eagle II Microprocessor
(Warren E. Collins, Inc., Braintree, MA). Standard proce-
dures of the American Thoracic Society [30] were followed
at all examinations. Daily checks for leaks, volume cali-
bration with a 3-liter syringe and weekly calibration in the
4–7 liter range were undertaken to minimize methodo-
logical artifacts between exams. We analyzed FVC and
FEV1 as the maximum of five satisfactory maneuvers and
represented as percent of predicted [12,31-34]. In almost
all cases, the maximum and second highest maneuvers
agreed to within 150 ml.
Year 0 (baseline) BMI, divided into quartiles, was the pri-
mary predictor variable. The use of standard NHLBI BMI
based adiposity categories to categorize the distribution of
BMI in this population resulted in unequal distribution of
the population in each category and prevented the
detailed evaluation of lung function in thin participants at
baseline (Table 1); furthermore, participants changed cat-
egories during follow-up. Hence study specific year 0
(baseline) BMI quartile cutpoints were used as the pri-
mary predictor variable. However, the percentage of peo-
ple progressing to different obesity categories (as defined
by standard NHLBI cutoffs: normal, < 25 kg/m2; over-
weight, ≥ 25 kg/m2 – < 30 kg/m2; and obese, ≥ 30 kg/m2)
within each baseline BMI category over a 10 year period
was calculated [35]. Change in BMI was evaluated as an
additional predictor variable. Participants were divided
into three age groups: 18–21 years, 22–26 years, and 27–
30 years based on their year 0 age. The effect of BMI on
lung function was evaluated in these 3 age groups sepa-
rately.
Statistical Methods
We considered that methodological differences might
exist between examinations, reflecting small changes in
spirometry procedures that occurred by using different
technicians across examinations, despite the formal pro-
cedures remaining the same. As the first analytic step, we
estimated such methodological differences adjusting for
race, gender, age, age2, height, and height2 by subtracting
the mean lung function value for participants of a given
age at a later exam from the mean lung function value for
other participants of the same age at an earlier examina-
tion, then averaging over ages (age-matched calendar time
differences) using the method of Jacobs et al. [36]. Rela-
tive to year 10 measurements, we added 53 ml, 54 ml, and
16 ml to the predicted FVC at year 0, 2, and 5, respectively;
added 6 and 21 ml to the predicted FEV1 at years 0 and 2,
and subtracted 25 ml from the predicted FEV1 at year 5;
and subtracted 0.94, 0.55, and 0.91 units from 100* the
predicted FEV1/FVC ratio at the respective years.
Analyses of lung function and BMI relationships in three
narrow age ranges allowed us to separate the cross-sec-
tional and longitudinal relationships as people went
through different phases of lung development, plateau,
and decline [9,37-39]. Longitudinal changes in lung func-
tion over 10 years, as estimated by FVC, FEV1, and FEV1/
FVC at years 0, 2, 5, and 10 were estimated within each age
group across different baseline BMI quartiles. Using the
lung values corrected for methodological differences, a
repeated measures regression model (SAS PROC MIXED)
adjusted for current age, time, race, sex, height, age group
category, smoking status, physical activity, and alcohol
intake (all at baseline) and baseline prevalence and inci-
dence of asthma [9,36,38,39] was used to estimate the
association of baseline BMI with lung function. The cov-
ariates were selected a priori based on their associations
with the variables of interest. Linearity assumptions and
goodness of fit were verified by examining the sequence of
mean dependent variable values at each age within each
BMI category in reference to the fitted lines. Goodness of
fit was adequate (data not shown). Serial correlation was
Table 1: Comparison of classification using NHLBI BMI cutpoints with that using the CARDIA baseline BMI quartiles
Quartiles of baseline BMI [n (% in row)]
Categories of baseline BMI based on NHLBI 
BMI cutpoints
Q1 <21.3 kg/m2 Q2 21.3–<23.4 kg/m2 Q3 23.4–<26.4 kg/m2 Q4 ≥ 26.4 kg/m2
<18.5 kg/m2 193 (100) 0 (0) 0 (0) 0 (0)
18.5–24.9 kg/m2 990 (35) 1184 (41) 683 (24) 0 (0)
25–29.9 kg/m2 0 (0) 0 (0) 500 (45) 621 (55)
≥ 30 kg/m2 0 (0) 0 (0) 0 (0) 563 (100)Respiratory Research 2008, 9:31 http://respiratory-research.com/content/9/1/31
Page 4 of 10
(page number not for citation purposes)
modeled as compound symmetry. We estimated the effect
of concurrent change in BMI from year 0 to year 10 on
lung function using a repeated measures regression with
change in the lung parameter as the dependent variable (3
repeats: year 2 – year 0, year 5 – year 0, and year 10 – year
0), and baseline BMI quartiles, change in BMI in 5 catego-
ries, and their interaction as the independent variables of
interest. The 4 categories of least change in BMI stratified
a large number of people, while the highest category
allowed a closer evaluation of change in lung function
among those who gained a considerable amount of
weight (≥ 6 kg/m2). In analyses evaluating the association
between change in BMI and change in lung function, we
added as covariates change in smoking status, change in
physical activity, and change in alcohol intake. People
who were heavier at baseline tended to gain more weight
over 10 years than did people who were lighter. Therefore
this additional model evaluated how much of the lung
function and BMI relationship persisted after accounting
for subsequent weight change. It also evaluated the rela-
tionship of lung function to change in BMI itself. For com-
parison with the model of change since baseline, we also
examined a transition model [40] in which the repeated
changes were for year 2 – year 0, year 5 – year 2, and year
10 – year 5. Here a BMI increase ≥ 6 kg/m2 was rare given
that the maximum time interval between examinations
was 5 years, so the highest BMI change category was ≥ 2.5
kg/m2.
Results
Description of Study Population
The study sample at year 0 was aged 24.9 ± 3.6 years
(Table 2). There were 1017 in the 18–21 year old birth
cohort (mean age 19.6 years), 1842 in the 22–26 year old
cohort (mean age 24.1), and 1875 in the 27–30 year old
cohort (mean age 28.5). By design, the participants were
evenly distributed among race-sex groups. Thirty nine per-
cent had no education past high school. 2225 had never
smoked and never had asthma either prior to year 0 or
during the 10 years of study. Quartile cut points for year 0
BMI, computed before exclusion for missing covariates,
were: 25th percentile 21.2 kg/m2, median 23.4 kg/m2, and
75th percentile 26.4 kg/m2. A higher percentage of partic-
ipants were black in the highest BMI quartile as compared
to lower BMI quartiles (64% vs. 46%). Progression in
NHLBI BMI-based adiposity categories [35] is depicted in
Figure 1. Overall, the mean increase in BMI over 10 years
was 3.0 ± 3.5 (SD) kg/m2. Category cut points 0, 1, 2.5,
and 6 kg/m2 for 5 categories of change in BMI were
selected to represent weight loss and gradations of weight
Table 2: Characteristics of the participants at year 0 according to baseline BMI quartiles, the CARDIA study, 1985–96
Quartiles of Baseline BMI
Q1 <21.3 kg/m2 Q2 21.3–<23.4 kg/m2 Q3 23.4–<26.4 kg/m2 Q4 ≥ 26.4 kg/m2
(n = 1117) (n = 1191) (n = 1215) (n = 1211)
Age (Years) 24.3 (3.7) 24.7 (3.5) 25.1 (3.6) 25.3 (3.5)
FVC (L) 4.02 (0.88) 4.40 (0.96) 4.58 (1.06) 4.19 (1.05)
FEV1 (L) 3.38 (0.68) 3.64 (0.75) 3.74 (0.82) 3.44 (0.82)
FEV1/FVC 85 (7) 83 (6) 82 (6) 83 (6)
Physical activity (exercise units) 395 (275) 462 (299) 459 (317) 375 (290)
Alcohol (mg/day) 10.6 (19.0) 12.9 (22.8) 13.5 (21.0) 11.4 (22.4)
Education (% ≤ high school) 39.8 37.6 35.6 42.6
Race (Blacks) (%) 44.1 45.1 48.8 64.4
Sex (Male) (%) 32.6 51.2 57.5 43.0
Prevalence of asthma at year 0 (%) 9.0 9.2 10.9 10.2
Cumulative incidence of asthma during 10 years of follow-up (%)  6.8 4.9 5.4 8.1
Prevalence of ex-smokers (%) 14.2 13.0 15.1 12.1
Prevalence of current smoking ≤ 15 cigs/day (%) 21.7 21.6 19.1 20.9
Prevalence of current smoking > 15 cigs/day (%) 9.9 9.9 10.0 9.8
* Variables were measured at year 0 unless otherwise indicated. Values are means (standard deviations in parentheses) or percentages.
Presence of overweight and obesity according to NHLBI cut- points (overweight body mass index (BMI) 25–29 Figure 1
Presence of overweight and obesity according to 
NHLBI cutpoints (overweight body mass index (BMI) 25–
29.9 kg/m2, obese BMI ≥ 30 kg/m2), by quartile of baseline 
BMI; and progression over 10 years.Respiratory Research 2008, 9:31 http://respiratory-research.com/content/9/1/31
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gain. The increase in BMI tended to be larger, the higher
the initial BMI (Table 3).
Lung Function and BMI: Association between year 0 BMI 
and lung function
The change in FVC over a 10 year period differed across
baseline BMI quartiles (p < 0.0001). Average 10 year FVC
change was 71, 19, -72, and -185 ml in the lowest through
highest BMI quartile (Table 4), with the increase in the
low BMI participants being more pronounced in the
youngest birth cohort (Figure 2). The estimated mean FVC
generally increased for 5 years, then plateaued in all birth
cohorts in the thinnest people at baseline (Figure 2). A
pattern of increase and plateau is seen from mean age 19.6
years, with no decrease in FVC through mean age 38.5
years (Figure 2, oldest birth cohort, year 10). In contrast,
for those in the highest BMI quartile FVC decreased con-
tinuously over the same time period in all birth cohorts.
People in the second quartile of baseline BMI displayed a
tendency to increase FVC over 10 years, but less so than in
quartile 1 (data not shown) and people in the third quar-
tile of baseline BMI displayed a tendency to decrease FVC,
but less so than in quartile 4 (data not shown).
The change in FEV1 over a 10 year period also differed
across baseline BMI quartiles (p < 0.0001). The FEV1
change was 60, 18, -28, and -64 ml in the lowest through
highest BMI quartiles (Table 4), respectively, with the
increase in the low BMI participants being more pro-
nounced in the youngest birth cohort and no suggestion
of a decline in FEV1 through age 38 in the lowest BMI
quartile (Figure 3).
In contrast to the FVC and FEV1, estimated mean FEV1/
FVC tended to decrease in the thinnest participants for the
first 5 years and then increase over the next 5 year period
as compared to a continuous increase in the participants
in the highest baseline BMI quartile (Table 4, Figure 4); p
for changes in the ratio across BMI categories was <
0.0001 within each age group and did not vary signifi-
cantly by age group. Age-adjusted mean change in FEV1/
FVC (averaged across the 3 birth cohorts) was -0.07, 0.29,
1.00 and 2.03 in the lowest to highest BMI quartiles,
respectively (Table 4), with the initial decrease in the low
BMI participants being more pronounced in the youngest
cohort.
Findings were similar among the 2225 participants at year
0 who were never smokers and did not have asthma at any
time during the study (Table 4). Race and gender did not
significantly modify the association between year 0 BMI
and any of the lung function variables (data not shown).
Lung Function and BMI: Association Between Change in 
BMI and Change in Lung Function
Change in BMI was a significant predictor of FVC, FEV1,
and FEV1/FVC over the 10 year study period. The direction
of change in lung function according to change in BMI
FVC in year 0 BMI quartiles across three birth cohorts: 18– 21 years, 22–26 years, and 27–30 years at baseline, based on  repeated measures linear regression analysis and adjusted for  race, sex, current age, smoking status at year 0, asthma sta- tus, time, physical activity score at year 0, and alcohol con- sumption at year 0 Figure 2
FVC in year 0 BMI quartiles across three birth 
cohorts: 18–21 years, 22–26 years, and 27–30 years at 
baseline, based on repeated measures linear regres-
sion analysis and adjusted for race, sex, current age, 
smoking status at year 0, asthma status, time, physi-
cal activity score at year 0, and alcohol consumption 
at year 0. The slope of FVC across time becomes increas-
ingly negative with increasing year 0 BMI (p trend < 0.0001).
Table 3: Distribution of categories of 10 year change in BMI across baseline BMI quartiles
Quartiles of baseline BMI [n (% in column)]
Categories of Change in BMI Q1 <21.3 kg/m2 Q2 21.3–<23.4 kg/m2 Q3 23.4–<26.4 kg/m2 Q4 ≥ 26.4 kg/m2
≤ 0 kg/m2 115 (14) 149 (17) 146 (16) 138 (15)
0.1–0.9 kg/m2 137 (17) 128 (15) 103 (12) 63 (7)
1–2.4 kg/m2 232 (29) 227 (26) 187 (21) 136 (15)
2.5–5.9 kg/m2 254 (31) 270 (31) 323 (36) 292 (33)
≥ 6 kg/m2 70 (9) 102 (12) 132 (15) 263 (29)Respiratory Research 2008, 9:31 http://respiratory-research.com/content/9/1/31
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was dependent on year 0 BMI, but not on birth cohort (p
< 0.0001 for the interaction of change in BMI and baseline
BMI, Table 5). Averaging across the 3 birth cohorts, FVC
increased over the study period in the lowest BMI quartile
across all categories of change in BMI, although the
increase was least in those who lost weight (5 ml) or who
gained > 6 kg/m2 (5 ml) as compared to a increase in FVC
in those who gained 1–5.9 kg/m2 (15–65 ml) (p for differ-
ence for those who lost weight as compared to those who
gained 2.5–5.9 kg/m2 < 0.0001) (Table 5). In contrast, in
individuals in the highest baseline BMI quartile FVC
increased in those who lost weight (22 ml) or those who
FEV1/FVC in year 0 BMI quartiles across three birth cohorts:  18–21 years, 22–26 years, and 27–30 years at baseline, based  on repeated measures linear regression analysis and adjusted  for race, sex, current age, smoking status at year 0, asthma  status, time, physical activity score at year 0, and alcohol con- sumption at year 0 Figure 4
FEV1/FVC in year 0 BMI quartiles across three birth 
cohorts: 18–21 years, 22–26 years, and 27–30 years at 
baseline, based on repeated measures linear regres-
sion analysis and adjusted for race, sex, current age, 
smoking status at year 0, asthma status, time, physi-
cal activity score at year 0, and alcohol consumption 
at year 0. The slope of FEV1/FVC across time becomes 
increasingly positive with increasing year 0 BMI (p trend < 
0.0001).
Table 4: Estimated* 10 year change in FVC (mL), FEV1 (mL) and FEV1/FVC (%) across baseline BMI quartiles, overall and among never 
smokers who did not have asthma at baseline or during the study
Quartiles of baseline BMI 10-year Change in lung function value 
All participants FVC FEV1 FEV1/FVC
<21.2 kg/m2 71 (-43 – 184) 60 (-38 – 159) -0.07% (-1.40% – 1.26%)
21.3–<23.4 kg/m2 19 (-94 – 133) 18 (-79 – 116) 0.29% (-1.03% – 1.62%)
23.4–<26.4 kg/m2 -72 (-186 – 41) -28 (-125 – 70) 1.00% (-0.33% – 2.33%)
≥ 26.4 kg/m2 -185 (-298 – -71) -64 (-161 – 34) 2.03% (0.71% – 3.36%)
p trend <0.0001 <0.0001 <0.0001
Never smoker, never asthma
<21.2 kg/m2 129 (-37 – 294) 76 (-62 – 215) -0.84% (-2.63% – 0.95%)
21.3–<23.4 kg/m2 78 (-87 – 244) 29 (-109 – 168) -0.60% (-2.39% – 1.18%)
23.4–<26.4 kg/m2 -18 (-184 – 147) -28 (-166 – 111) 0.05% (-1.73% – 1.84%)
≥ 26.4 kg/m2 -138 (-304 – 27) -47 (-186 – 91) 1.60% (-0.19% – 3.39%)
p trend <0.0001 <0.0001 <0.0001
* Estimated FVC, FEV1 and FEV1/FVC were obtained using a repeated measures linear regression model to estimate lung function values over a 10 
year period across baseline BMI quartiles after adjusting for current age, (current age)2, race, gender, study center, height, (height)2, baseline age 
group, smoking status, asthma status, physical activity and alcohol intake all measured at baseline (year 0).
FEV1 in year 0 BMI quartiles across three birth cohorts: 18– 21 years, 22–26 years, and 27–30 years at baseline, based on  repeated measures linear regression analysis and adjusted for  race, sex, current age, smoking status at year 0, asthma sta- tus, time, physical activity score at year 0, and alcohol con- sumption at year 0 Figure 3
FEV1 in year 0 BMI quartiles across three birth 
cohorts: 18–21 years, 22–26 years, and 27–30 years at 
baseline, based on repeated measures linear regres-
sion analysis and adjusted for race, sex, current age, 
smoking status at year 0, asthma status, time, physi-
cal activity score at year 0, and alcohol consumption 
at year 0. The slope of FEV1 across time becomes increas-
ingly negative with increasing year 0 BMI (p trend < 0.0001).Respiratory Research 2008, 9:31 http://respiratory-research.com/content/9/1/31
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gained 0.1–0.9 kg/m2 (15 ml), but decreased progressively
as weight gain increased, reaching a loss of 264 ml in
those who gained > 6 kg/m2 (p for difference <0.0001).
Within each category of change in BMI, baseline BMI
remained a significant predictor of FVC (p value <
0.0001).
Averaging across all 3 birth cohorts, FEV1 decreased in all
baseline BMI quartiles across all categories of change in
BMI. In the lowest baseline BMI quartile, the decrease was
lower in those who lost weight (-38 ml) or gained mini-
mal weight (-31 ml) as compared to those who gained >
6 kg/m2 (-110 ml) during the same period (Table 5) (p for
difference for >6 kg/m2 as compared to those who lost
weight = 0.001). Individuals in the highest baseline BMI
quartile also lost increasing amounts of FEV1 with increas-
ing change in BMI (Table 5) (p for difference for > 6 kg/
m2 as compared to those who lost weight < 0.0001). The
magnitude of loss of FEV1 was higher in the highest base-
line BMI quartile as compared to the lowest baseline BMI
quartile.
The FEV1/FVC decreased among all participants. The
decrease in FEV1/FVC among the lowest baseline BMI
quartile was higher with increasing weight gain (p for dif-
ference for > 6 kg/m2 as compared to those who lost
weight < 0.0001) as compared to the decrease in FEV1/
FVC among the highest baseline BMI quartile with
increasing weight gain (p for difference = 0.01 for those
who gained > 6 kg/m2 as compared to those who lost
weight) (Table 5).
The transition model using year 2 – year 0, year 5 – year 2,
and year 10 – year 5 as repeats but otherwise parallel to
the model shown in Table 5 showed a similar pattern for
each lung function measure to that shown in Table 5, but
lung function changes for each BMI change category were
generally smaller than in Table 5, consistent with the
shorter exposure intervals being modeled (2, 3, and 5 year
intervals in the transition model, compared to 2, 5, and 10
year intervals in Table 5).
Restricting to participants who were never smokers and
never had asthma during the study, the direction and
magnitude of association between change in BMI and
FVC, FEV1, and FEV1/FVC was similar to that seen in the
entire population (data not shown). This similarity
included that change in BMI was a significant predictor of
FVC, FEV1 and FEV1/FVC within each baseline BMI cate-
gory (p <0.0001 for the interaction of change in BMI and
baseline BMI).
Discussion
We found strong associations between lung function and
BMI. As hypothesized, FVC and FEV1 generally decreased
over a 10 year period both with higher baseline BMI and
with increasing BMI over 10 years of follow-up. However,
the thinnest people (lowest baseline BMI quartile) gained
Table 5: Estimated* 10 year change in FVC (mL), FEV1 (mL) and FEV1/FVC (%) across different categories of change in BMI within 
baseline BMI quartiles
Quartiles of baseline BMI *+
<21.3 kg/m2 21.3–<23.4 kg/m2 23.4–<26.4 kg/m2 ≥ 26.4 kg/m2
2, 5 and 10 year FVC change (p interaction < 0.0001)
Categories of Change in BMI Q1 Q2 Q3 Q4
≤ 0 kg/m2 5 (-14 – 24) 32 (14 – 49) 49 (32 – 67) 22 (4 – 40)
0.1–0.9 kg/m2 15 (1 – 30) 22 (8 – 37) 22 (8 – 37) 15 (0 – 31)
1–2.4 kg/m2 53 (38 – 67) 19 (4 – 33) -13 (-27 – 2) -63 (-80 – -46)
2.5–5.9 kg/m2 65 (46 – 83) 1 (-17 – 18) -69 (-85 – -53) -146 (-161 – -130)
≥ 6 kg/m2 5 (-37 – 46) -96 (-132 – -60) -178 (-208 – -148) -264 (-286 – -243)
2, 5, and 10 year FEV1 change (p interaction < 0.0001)
Categories of Change in BMI Q1 Q2 Q3 Q4
≤ 0 kg/m2 -38 (-56 – -19) -18 (-35 – -2) -5 (-21 – 11) -11 (-22 – 6)
0.1–0.9 kg/m2 -31 (-45 – -17) -24 (-38 – -10) -22 (-36 – -8) -30 (-45 – -16)
1–2.4 kg/m2 -30 (-44 – -16) -60 (-73 – -46) -66 (-80 – -52) -81 (-97 – -64)
2.5–5.9 kg/m2 -54 (-71 – -36) -95 (-111 – -78) -121 (-137 – -106) -136 (-151 – -121)
≥ 6 kg/m2 -110 (-149 – -70) -147 (-181 – -112) -201 (-230 – -173) -216 (-236 – -195)
2, 5, and 10 year FEV1/FVC change (p interaction < 0.0001)
Categories of Change in BMI Q1 Q2 Q3 Q4
≤ 0 kg/m2 -0.96 (-1.30 – -0.63) -1.03 (-1.33 – -0.74) -0.99 (-1.29 – -0.70) -0.70 (-1.01 – -0.40)
0.1–0.9 kg/m2 -1.03 (-1.28 – -0.78) -1.03 (-1.28 – -0.78) -1.01 (-1.26 – -0.75) -1.01 (-1.27 – -0.74)
1–2.4 kg/m2 -1.85 (-2.10 – -1.61) -1.71 (-1.95 – -1.46) -1.24 (-1.49 – -0.98) -0.68 (-0.97 – -0.39)
2.5–5.9 kg/m2 -2.59 (-2.91 – -2.28) -2.18 (-2.47 – -1.89) -1.55 (-1.82 – -1.27) -0.51 (-0.78 – -0.25)
≥ 6 kg/m2 -3.30 (-4.01 – -2.59) -2.10 (-2.72 – -1.48) -1.60 (-2.12 – -1.08) -0.11 (-0.48 – 0.26)
* Estimated FVC, FEV1 and FEV1/FVC were obtained from a repeated measures linear regression model that evaluated the change in lung function 
from baseline over 2, 5 and 10 years across different baseline BMI quartiles after adjusting for current age, (current age)2, race, gender, study 
center, height, (height)2, age group, smoking status, asthma status, and alcohol intake all measured at baseline (year 0), change in smoking status, 
change in physical activity and change in alcohol intake (all over 2, 5 and 10 years).Respiratory Research 2008, 9:31 http://respiratory-research.com/content/9/1/31
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FVC and lost the least amount of FEV1 even as they gained
weight during the study. Furthermore, our estimates sug-
gested no clear decline in either FVC or FEV1 in the thin-
nest people even through age 38 regardless of concurrent
change in BMI. Plateauing of FVC over 10 years of follow-
up was observed in all three baseline age groups, suggest-
ing that the observed evolution of FVC was not an artifact
of grouping people who achieve their peak lung function
at different times [41].
The finding of a decrease in lung function with increasing
baseline BMI is in agreement with several cross-sectional
studies that found associations of FVC and FEV1 with BMI
[10-12,18] and other longitudinal studies that found that
weight gain is associated with more rapid loss of lung
function [13-17,20]. While many of these studies looked
at populations at risk for reduced lung function (smokers
[13] steel workers, [13,14] or shipyard workers [18]), our
study involved a large, generally healthy, young adult
sample whose characteristics were much closer to those of
the general population than was the case in the other stud-
ies. Contrary to what has been reported, we found main-
tenance of high levels of lung function in the thinnest
people (lowest baseline BMI quartile) even through age
38 [42].
FVC as determined by spirometry reflects total compli-
ance, which has contributions from both the lung and
chest wall. The FEV1 reflects these same factors plus airway
resistance. In a normal healthy population, the decrease
in elasticity with age has a greater effect on FEV1 as com-
pared to FVC, resulting in a decrease in FEV1/FVC. How-
ever, among the participants with high BMI the FEV1/FVC
is larger and the loss of elasticity has a greater effect on
FVC as compared to FEV1 resulting in an increase in FEV1/
FVC in this subgroup. This is substantiated by our results
which show an increase in FEV1/FVC over 10 years among
participants in the highest BMI category. Increasing year 0
BMI and subsequent weight gain within each BMI quartile
can decrease FVC and FEV1 by decreasing chest wall com-
pliance and/or increasing the circulating levels of
cytokines. Increased adiposity has been associated with
increased levels of cytokines such as IL-6 and TNF-alpha
[43], and decreased levels of adiponectin [43,44], thereby
increasing the levels of systemic inflammation, which
might in turn negatively affect lung function. We have pre-
viously reported from these data worse lung function in
those with higher values for plasma fibrinogen [45].
Increases in both FVC and FEV1 over 10 years in the lowest
year 0 BMI quartile and maintenance of relatively high
FVC and FEV1  values even in those thin people who
reached their mid 30s during the study is contrary to what
has been previously described [42]. In addition, FVC
increased in the lowest baseline BMI quartile with increas-
ing change in BMI while FEV1 decreased minimally. We
consider the possibility that the associations between lung
function and BMI observed here are not solely due to the
mechanical properties of the chest wall. Lower levels of
cytokines and less baseline systemic inflammation in peo-
ple with low baseline BMI may also explain the observed
longitudinal increase in FEV1 and FVC even when there
was a subsequent increase in BMI. For example, a thin per-
son at baseline whose BMI increases by 5 kg/m2 would
still only have a BMI of 24 kg/m2 at year 10. However,
serial measurements of cytokines and measures of chest
wall compliance are not available to adequately address
cytokine behavior or chest wall dynamics in the different
baseline BMI and BMI change categories.
The increases in FVC and FEV1 observed in the lowest
baseline BMI quartile were more pronounced in the
youngest birth cohort as compared to the other birth
cohorts. Since the people in the youngest age group may
still be increasing their lung function, increasing BMI in
them could preferentially reflect lean mass, which may
have a positive effect on lung function early in adult life,
as compared to the detrimental effect in older adults
where the increase in BMI more likely represents increas-
ing adiposity [46,47]. This is consistent with the results
from another study that showed a positive effect of child-
hood BMI on adult FVC and FEV1 [48].
The present study has several strengths, including the large
number of participants, their relatively narrow age range
at entry, inclusion of blacks and whites and men and
women, and the long duration of follow-up including the
period in which peak lung function is achieved. It also
assured a high quality of data collection through strict
quality control across examinations. Because the sample
studied by CARDIA included young, healthy people, few
individuals were lost due to disease, avoiding survivorship
bias [49]. 3146 participants completed all 4 spirometry
tests, 1159 completed 3, 502 completed 2, and 285 com-
pleted only 1 test. Parallel analyses in the constant cohort
(not missing lung function at any of the 4 examinations
(n = 3062 after excluding missing covariates) led to simi-
lar results (data not shown), indicating that there was not
a substantial bias due to missing observations in this
study.
Limitations of the current study include biases common
to longitudinal study, such as bias introduced due to loss
of follow up. This bias is minimized in CARDIA due to the
excellent retention of the original cohort and because
there was no difference in baseline lung function meas-
ures between those who were lost to follow up and those
who continued to participate in the study. Standardizing
serial lung function measurements requires technician
training and careful adherence to written test protocols.
We used standardized measurement techniques andRespiratory Research 2008, 9:31 http://respiratory-research.com/content/9/1/31
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trained technicians to perform spirometry measurements
over the 10 year period. In spite of these efforts, we
observed a secular trend with FVC values obtained at year
10 being lower than those obtained in the earlier time
points and FEV1 values being higher at year 0 and 2 and
lower at year 5 as compared to year 10 values. We adjusted
for this trend during our analysis to minimize the effect of
this secular trend on the study results.
In conclusion, participants in this study who were thin at
age 18–30 did not experience a decline in FVC and FEV1
through their mid 30s. In contrast, increasing BMI in
heavier people, particularly those who had a BMI ≥ 26.4
kg/m2, 79% of whom had become obese by year 10, was
associated with a rapid decrease in FVC and FEV1 and an
almost constant FEV1/FVC ratio. Loss of lung function by
age 38 was not inevitable in these healthy young adults,
although those with highest BMI suffered substantial
losses starting as early as age 20. Whatever the predomi-
nant mechanism(s) responsible for these changes might
be, these data indicate that maximal lung function may be
maintained well into the fourth decade of life; and that, in
addition to its other effects on health and disease, the
obesity epidemic may threaten the lung function and as a
consequence the lung health of the general population.
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